Antipsychotic drugs and risk of pulmonary embolism.

Allenet B, Schmidlin S, Genty C, Bosson J-L. Antipsychotic drugs and risk of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2012;21(1):42-8. DOI: 10.1002/pds.2210. PubMed PMID: 22052683.

Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden.

Einarson TR, Vicente C, Zilbershtein R, Piwko C, Bø CN, Pudas H, et al.. Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden. Nord J Psychiatry. 2014;68(6):416-27. DOI: 10.3109/08039488.2013.852243. PubMed PMID: 24274837.

Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012).

Balda MV, Garay OU, Papale RM, Bignone I, Bologna VG, Brandolini A, et al. Clozapine-associated neutropenia and agranulocytosis in Argentina (2007-2012). Int Clin Psychopharmacol. 2015;30(2):109-14. DOI: 10.1097/YIC.0000000000000060. PubMed PMID: 25486383.

Practical guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities.

de Leon J, Greenlee B, Barber J, Sabaawi M, Singh NN. Practical guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities. Res Dev Disabil. 2009;30(4):613-69. DOI: 10.1016/j.ridd.2008.10.010. PubMed PMID: 19084370.

Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial.

Joffe G, Takala P, Tchoukhine E, Hakko H, Raidma M, Putkonen H, et al. Orlistat in clozapine- or olanzapine-treated patients with overweight or obesity: a 16-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2008;69(5):706-11. PubMed PMID: 18426261.

Medical management of patients on clozapine: A guide for internists.

Lundblad W, Azzam PN, Gopalan P, Ross CA. Medical management of patients on clozapine: A guide for internists. J Hosp Med. 2015;10(8):537-43. DOI: 10.1002/jhm.2345. PubMed PMID: 25809850.

Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.

Samara MT, Dold M, Gianatsi M, Nikolakopoulou A, Helfer B, Salanti G, et al. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Jama Psychiatry. 2016;73(3):199-210. DOI: 10.1001/jamapsychiatry.2015.2955. PubMed PMID: 26842482.

Risk of venous thromboembolism due to antipsychotic drug therapy.

Hägg S, Jönsson AK, Spigset O. Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf. 2009;8(5):537-47. DOI: 10.1517/14740330903117271. PubMed PMID: 19569978.

Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia.

Richardson CM, Davis EA, Vyas GR, Dipaula BA, McMahon RP, Kelly DL. Evaluation of the Safety of Clozapine Use in Patients With Benign Neutropenia. J Clin Psychiatry. 2016;77(11):e1454-e1459. DOI: 10.4088/JCP.15m10315. PubMed PMID: 27736047.

Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective.

Tang C, Subramaniam M, Ng BT, Abdin E, Poon LY, Verma SK. Clozapine Use in First-Episode Psychosis: The Singapore Early Psychosis Intervention Programme (EPIP) Perspective. J Clin Psychiatry. 2016;77(11):e1447-e1453. DOI: 10.4088/JCP.15m10063. PubMed PMID: 27736048.